Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Use of Intravenous Immunoglobulin (IVIG) during Severe Neurotoxicity Among the Recipients of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Sepideh Mokhtari, MD, Justin M Asquith, MD, Christina A Bachmeier, PharmD, Michael D. Jain, MD PhD, Peter Forsyth, MD, Frederick L. Locke, MD, Youngchul Kim, PhD, Aleksandr Lazaryan, MD PhD MPH

Blood (2019) 134 (Supplement_1): 5627.

https://doi.org/10.1182/blood-2019-122343

Published: 2019

Journal Articles

Radiation Therapy As a Bridging Strategy for Refractory Diffuse Large B Cell Lymphoma Patients Awaiting CAR T Manufacturing of Axicabtagene Ciloleucel

Michael D. Jain, MD PhD, Julio C. Chavez, MD, Bijal D. Shah, MD, Farhad Khimani, MBBS, Aleksandr Lazaryan, MD PhD MPH, Marco L. Davila, MD PhD, Hien D. Liu, MD, Aaron D Falchook, MD, Timothy Robinson, MD, Sungjune Kim, MD PhD, Frederick L. Locke, MD

Blood (2018) 132 (Supplement 1): 4220.

https://doi.org/10.1182/blood-2018-99-117133

Published: 2018

Journal Articles

Increased Risk of Second Primary Hematologic and Solid Malignancies in Patients with Mycosis Fungoides

Amrita Goyal, MD, Daniel O'Leary, MD, Aleksandr Lazaryan, MD PhD MPH

Blood (2018) 132 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2018-99-111713

Published: 2018

Journal Articles

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

Blood (2017) 130 (Supplement 1): 72.

https://doi.org/10.1182/blood.V130.Suppl_1.72.72

Published: 2017

Journal Articles

Prognostic Significance of Cytogenetic Abnormalities in Patients with Philadelphia-Negative ALL Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission: A CIBMTR Analysis

Aleksandr Lazaryan, MD PhD MPH, Michelle Dolan, MD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Veronika Bachanova, MD PhD, Marcos De Lima, MD, Brenda M. Sandmaier, MD, Daniel J. Weisdorf, MD

Blood (2017) 130 (Supplement 1): 1439.

https://doi.org/10.1182/blood.V130.Suppl_1.1439.1439

Published: 2017

Journal Articles

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Livia Hegerova, MD, Adam Bachan, Qing Cao, MS, Veronika Bachanova, MD PhD, Mark Reding, MD, John Rogosheske, PharmD, Brian McClune, DO, Aleksandr Lazaryan, MD PhD MPH, Greg M Vercellotti, MD FACP, Huong X Vu, PharmD

Blood (2017) 130 (Supplement 1): 3695.

https://doi.org/10.1182/blood.V130.Suppl_1.3695.3695

Published: 2017

Journal Articles

Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study

Navneet S. Majhail, MD MS, Sergey Tarima, PhD, Ellen Denzen, MS, Heather Moore, MPH, Sunil Abhyankar, MD, Peter Dawson, PhD, Amy Foley, Iris D. Gersten, MS, Mitchell E. Horwitz, MD, Lensa Idossa, MPH, Steven Joffe, MDMPH, Naynesh Kamani, MD, Roberta King, MPH, Aleksandr Lazaryan, MD PhD MPH, Lawrence E Morris, MD, Mary M. Horowitz, MD MS, Ryan Spellecy, PhD

Blood (2017) 130 (Supplement 1): 4687.

https://doi.org/10.1182/blood.V130.Suppl_1.4687.4687

Published: 2017

Journal Articles

Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease

Aleksandr Lazaryan, MD PhD MPH, Stephanie J Lee, MD MPH, Amandeep Salhotra, MD, Madan Jagasia, MD MBBS, MS, James Essell, MD, Alexandra Zanin-Zhorov, PhD, Beth Mac Gillivray, MSc, Olivier Schueller, PhD, David Eiznhamer, PhD, Bruce Blazar, MD, John L. Ryan, MD PhD

Blood (2017) 130 (Supplement 1): 3256.

https://doi.org/10.1182/blood.V130.Suppl_1.3256.3256

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Elderly Patients: Prognosis Determined By Disease Risk Index

Fiona C. He, MD, Aleksandr Lazaryan, MD PhD MPH, Qing Cao, M.S., Claudio G Brunstein, MD, Shernan G. Holtan, MD, Erica D. Warlick, MD, Celalettin Ustun, MD, Brian McClune, DO, Mukta Arora, MD, Daniel J. Weisdorf, MD, Nelli Bejanyan, MD

Blood (2016) 128 (22): 2305.

https://doi.org/10.1182/blood.V128.22.2305.2305

Published: 2016

Journal Articles

Consolidation Chemotherapy Is Not Beneficial for Adult Acute Lymphoblastic Leukemia Patients with Available Donor Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation in First Complete Remission: A CIBMTR Study

Nelli Bejanyan, MD, Aleksandr Lazaryan, MD PhD MPH, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Marcos de Lima, MD, Brenda M. Sandmaier, MD, Mary M. Horowitz, MD MS, H. Jean Khoury, MD, Daniel J. Weisdorf, MD

Blood (2016) 128 (22): 684.

https://doi.org/10.1182/blood.V128.22.684.684

Published: 2016

Journal Articles

Similar Survival after Umbilical Cord Blood (UCB) and HLA-Matched Adult Donor Transplantation By Disease Risk Index (DRI) Assignment

Nelli Bejanyan, MD, Claudio G Brunstein, MD, Qing Cao, Aleksandr Lazaryan, MD PhD MPH, Erica D. Warlick, MD, Celalettin Ustun, MD, Shernan G. Holtan, MD, Mukta Arora, MD, Veronika Bachanova, MD, Michael R. Verneris, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD

Blood (2015) 126 (23): 4375.

https://doi.org/10.1182/blood.V126.23.4375.4375

Published: 2015

Journal Articles

What Predicts Success for a New Composite Endpoint: Graft–versus-Host Disease-Free and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation?

Shernan G. Holtan, MD, Todd E. DeFor, MS, Aleksandr Lazaryan, MD PhD MPH, Nelli Bejanyan, MD, Mukta Arora, MD MS, Bruce R. Blazar, MD, Margaret L. MacMillan, MD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 429.

https://doi.org/10.1182/blood.V124.21.429.429

Published: 2014

Journal Articles

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Veronika Bachanova, MD, Arthur Frankel, Qing Cao, MS, Dixie Lewis, Michael Verneris, MD, Aleksandr Lazaryan, MD PhD MPH, Linda J. Burns, MD, Daniel Vallera, PhD

Blood (2014) 124 (21): 3098.

https://doi.org/10.1182/blood.V124.21.3098.3098

Published: 2014

Journal Articles

Clinical Relevance of HLA Supertype Matching after Myeloablative Conditioning 7/8 Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Study

Aleksandr Lazaryan, MD PhD MPH, Tao Wang, PhD, Stephen R. Spellman, MBS, Hai-Lin Wang, MPH, Carlheinz R. Müller, MD PhD, Marcelo A. Fernandez-Viña, PhD D(ABHI), Michael R. Verneris, MD, Mukta Arora, MD MS, Daniel J. Weisdorf, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD MPH

Blood (2014) 124 (21): 2572.

https://doi.org/10.1182/blood.V124.21.2572.2572

Published: 2014

Journal Articles

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Aleksandr Lazaryan, MD PhD MPH, Todd E. DeFor, MS, Claudio Brunstein, MD, Margaret L. MacMillan, MD, Nelli Bejanyan, MD, Shernan G. Holtan, MD, Bruce R. Blazar, MD, John E Wagner, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 189.

https://doi.org/10.1182/blood.V124.21.189.189

Published: 2014

Journal Articles

Comparison of Quality of Life Outcomes and Psychosocial Functioning Between Patients Undergoing Myeloablative or Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

Aleksandr Lazaryan, MD, PhD, MPH, Betty K. Hamilton, MD, Linda McLellan, LISW, Lisa Rybicki, MS, Larry Foster, Ph.D., Michele Cooper, LISW, Jane Dabney, LISW, Shawnda Tench, Ronald Sobecks, MD, Hien Duong, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2011) 118 (21): 843.

https://doi.org/10.1182/blood.V118.21.843.843

Published: 2011

Journal Articles

Poor Mobilization of CD34+ Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma

Aleksandr Lazaryan, MD, PhD, MPH, Hien Duong, MD, Lisa Rybicki, MS, Frederic J. Reu, MD, Robert Dean, MD, Ronald Sobecks, MD, Shawnda Tench, Edward A. Copelan, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD

Blood (2011) 118 (21): 3000.

https://doi.org/10.1182/blood.V118.21.3000.3000

Published: 2011

Journal Articles

Prognostic Significance of Bone Marrow Involvement At Diagnosis and At the Time of Autologous Stem Cell Transplantation for Lymphoma Relapse,

Aleksandr Lazaryan, MD, PhD, MPH, John Sweetenham, M.D., Lisa Rybicki, MS, Robert Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD, PhD, Hien Duong, Ronald Sobecks, MD, Steven Andresen, DO, Shawnda Tench, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2011) 118 (21): 4122.

https://doi.org/10.1182/blood.V118.21.4122.4122

Published: 2011

Journal Articles

Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation.

Nelli Bejanyan, MD, Aleksandr Lazaryan, MD, PhD, MPH, Lisa Rybicki, MS, Shawnda Tench, Steven Andresen, DO, Ronald Sobecks, MD, Robert Dean, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2010) 116 (21): 1532.

https://doi.org/10.1182/blood.V116.21.1532.1532

Published: 2010

NARROW

The Use of Intravenous Immunoglobulin (IVIG) during Severe Neurotoxicity Among the Recipients of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Radiation Therapy As a Bridging Strategy for Refractory Diffuse Large B Cell Lymphoma Patients Awaiting CAR T Manufacturing of Axicabtagene Ciloleucel

Increased Risk of Second Primary Hematologic and Solid Malignancies in Patients with Mycosis Fungoides

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

Prognostic Significance of Cytogenetic Abnormalities in Patients with Philadelphia-Negative ALL Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission: A CIBMTR Analysis

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study

Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease

Allogeneic Hematopoietic Cell Transplantation for Elderly Patients: Prognosis Determined By Disease Risk Index

Consolidation Chemotherapy Is Not Beneficial for Adult Acute Lymphoblastic Leukemia Patients with Available Donor Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation in First Complete Remission: A CIBMTR Study

Similar Survival after Umbilical Cord Blood (UCB) and HLA-Matched Adult Donor Transplantation By Disease Risk Index (DRI) Assignment

What Predicts Success for a New Composite Endpoint: Graft–versus-Host Disease-Free and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation?

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Clinical Relevance of HLA Supertype Matching after Myeloablative Conditioning 7/8 Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Study

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Comparison of Quality of Life Outcomes and Psychosocial Functioning Between Patients Undergoing Myeloablative or Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

Poor Mobilization of CD34+ Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma

Prognostic Significance of Bone Marrow Involvement At Diagnosis and At the Time of Autologous Stem Cell Transplantation for Lymphoma Relapse,

Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only